Skip to content

Risk Assessment of Neurogenic Heterotopic Ossification in Spinal Cord Injury

Risk Assessment of Neurogenic Heterotopic Ossification in Spinal Cord Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109733
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic Heterotopic Ossification

Interventions

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for patients with neurogenic heterotopic ossification (NHO) spinal cord injury (SCI): (1) History of traumatic or non-traumatic SCI, such as myelitis, vascular malformations of the spinal cord, etc.; (2) Clinical manifestations of sensory, motor, and reflex dysfunction below the affected area (including complete and incomplete types); (3) Computed tomography (CT) or magnetic resonance imaging (MRI) showing spinal cord injury; (4) American Spinal Injury Association (ASIA) functional classification grades A-D. 2. Inclusion criteria for patients with neurogenic heterotopic ossification (NHO) spinal cord injury (SCI):(1) Meet all criteria for SCI patients without NHO;(2) Diagnosed with ectopic ossification formation through imaging examinations (such as CT and X-rays).

Exclusion criteria

Exclusion criteria: 1. Patients with brain diseases such as traumatic brain injury and stroke; 2. Those with primary skeletal diseases, metabolic diseases, or endocrine diseases affecting skeletal development and metabolism; 3. Individuals with fractures surrounding the site of heterotopic ossification.

Design outcomes

Primary

MeasureTime frame
Risk assessment;

Countries

China

Contacts

Public ContactYinxu Wang

Affiliated Hospital of North Sichuan Medical College

34089681@qq.com+86 134 3878 1951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026